Miriam Ibrahim
Physical Medicine & Rehabilitation · Muncie, INNPI 1194768549
Payments from drug & device makers
What this record shows
25 manufacturers reported payments, led by AbbVie at 59.0% of the total. Reporting peaked in 2020 at $1,269 and has fallen 81.8% since, to $231 in 2025.
Across 46 payments — averaging $48.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Biogen$125
- Medtronic$116
- Lilly USA, LLC$112
- Biohaven Pharmaceuticals, Inc.$92
- Exact Sciences$46
- plus $424 from 19 others
What the payments were for
- Speaking & faculty fees$1,22555%
- Food & beverage$1,00645%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $1,316 |
| Biogen | 1 | $125 |
| Medtronic(2 entities) | 2 | $116 |
| Lilly USA, LLC | 3 | $112 |
| Biohaven Pharmaceuticals, Inc. | 1 | $92 |
| Exact Sciences | 3 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Amgen | 2 | $36 |
| Corium, LLC | 2 | $35 |
| Pfizer | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $26 |
| Bayer | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Shionogi Inc | 1 | $13 |
| Noven Therapeutics, LLC | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Fidia Pharma USA Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,231 in reported general payments places this provider in the 75th percentile of 140 physical medicine & rehabilitation providers in Indiana.
See all physical medicine & rehabilitation providers in Indiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 36 | $2,572 |
| Celecoxib | 28 | $1,501 |
| Duloxetine Hcl | 97 | $1,283 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 65 | $1,278 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $884 |
| Pregabalin | 47 | $690 |
| Quetiapine Fumarate | 44 | $550 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $492 |
| Cyclobenzaprine Hcl | 45 | $465 |
| Gabapentin | 32 | $367 |
| Escitalopram Oxalate | 13 | $207 |
| Oxycodone Hcl | 12 | $149 |
| Tramadol Hcl | 13 | $144 |
| Meloxicam | 18 | $15 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Muncie
- Karen MillerMuncie$1K
- Christina WalzFort Wayne$503K
- Shashank DaveIndianapolis$198K
- Sayed WaheziFort Wayne$161K
- Andrew DavissonNew Castle$74K
- Sachin MehtaIndianapolis$60K
- David StenslandFort Wayne$24K
- Scott TaylorNew Castle$18K
- Jeffrey BeckTerre Haute$10K
- Daniel RothFort Wayne$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.